Mani Daneshmand, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Atlanta, GANPI 1962676700
Payments from drug & device makers
Across 266 payments — averaging $3474.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Transmedics, Inc.$430K
- Xvivo Perfusion Inc.$260K
- Abbott$148K
- Briohealth Solutions, Inc.$58K
- Atricure, Inc.$13K
- Abiomed$6K
- plus $10K from 7 others
Across 8 payments — averaging $161.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Transmedics, Inc.$662
- Carmat$632
What the payments were for
- Consulting fees$3,92919%
- Speaking & faculty fees$2,75013%
- Travel & lodging$10,66651%
- Food & beverage$3,35416%
- Education$2451%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Transmedics, Inc. | 74 | $429,505 |
| Xvivo Perfusion Inc. | 35 | $259,983 |
| Abbott | 83 | $147,887 |
| Briohealth Solutions, Inc. | 12 | $58,030 |
| Atricure, Inc. | 13 | $12,665 |
| Abiomed | 26 | $6,124 |
| United Therapeutics Corporation | 2 | $4,709 |
| Fresenius USA Marketing, Inc. | 8 | $4,260 |
| Medtronic(2 entities) | 4 | $341 |
| Getinge USA Sales, LLC | 5 | $317 |
| Paragonix Technologies, Inc. | 1 | $197 |
| Edwards Lifesciences | 2 | $107 |
| Johnson & Johnson | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$8,625
- Impella$2,178
- HeartMate 3 Left Ventricular Assist Device$751
- SherpaPak$197
- LIVERguard$197
- LUNGguard$197
- BaroGuard$197
- PancreasPak$197
- ADVISOR$165
- HeartWare HVAD$159
- HeartMate Touch$157
- CARDIOMEMS$131
- EPI-EASE EPICARDIAL ACCESS SYSTEM$120
- ATRICURE ATRICLIP LAA EXCLUSION$111
- CARDIOHELP$105
How this compares
$924,180 in reported general payments places this provider in the 95th percentile of 144 thoracic surgery (cardiothoracic vascular surgery) providers in Georgia.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 25 | $9,809 |
| Enoxaparin Sodium | 18 | $1,700 |
| Mycophenolate Mofetil | 15 | $910 |
| Pantoprazole Sodium | 24 | $178 |
| Metoprolol Tartrate | 20 | $101 |
| Atorvastatin Calcium | 21 | $90 |
| Pravastatin Sodium | 14 | $58 |
| Alendronate Sodium | 14 | $53 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $15 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Atlanta
- Robert GuytonAtlanta$1.3M
- John PuskasAtlanta$1.1M
- Jeffrey MillerAtlanta$877K
- Manu SanchetiAtlanta$805K
- James KautenAtlanta$599K
- William BrownAtlanta$483K
- Bradley LeshnowerAtlanta$427K
- John VegaAtlanta$377K
- Ezequiel MolinaAtlanta$337K
- Douglas MurphyAtlanta$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.